SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 323 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 4.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $481,000 | -96.5% | 19,100 | -91.7% | 0.76% | -23.0% |
| Q2 2018 | $13,721,000 | +64.7% | 229,253 | +26.1% | 0.99% | +58.1% |
| Q1 2018 | $8,329,000 | -20.4% | 181,846 | -25.1% | 0.63% | -17.7% |
| Q2 2017 | $10,458,000 | -7.1% | 242,661 | -32.5% | 0.76% | -2.9% |
| Q1 2017 | $11,259,000 | +69.4% | 359,739 | +36.7% | 0.78% | +71.4% |
| Q4 2016 | $6,645,000 | +62.4% | 263,184 | +59.0% | 0.46% | +55.3% |
| Q3 2016 | $4,093,000 | -41.9% | 165,511 | -67.1% | 0.30% | -41.0% |
| Q3 2015 | $7,047,000 | -17.4% | 502,319 | 0.0% | 0.50% | -21.4% |
| Q2 2015 | $8,529,000 | – | 502,319 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |